Related Experiment Videos
Clinical experience with SonoVue in myocardial perfusion imaging
D Rovai1, M A Morales, R Amyot
1CNR, Clinical Physiology Institute, Via Savi, 8, 56126 Pisa, Italy. drovai@ifc.pi.cnr.it
Echocardiography (Mount Kisco, N.Y.)
|November 1, 2000
Summary
Ultrasound-enhancing agents like SonoVue show promise for evaluating myocardial perfusion with echocardiography. This safe agent can identify perfusion issues, enhancing diagnostic capabilities in cardiology.
Area of Science:
- Cardiology
- Medical Imaging
- Pharmacology
Background:
- Echocardiography is a key diagnostic tool in cardiology.
- Assessing myocardial perfusion is crucial for diagnosing heart conditions.
- Traditional methods for myocardial perfusion assessment have limitations.
Observation:
- SonoVue is an intravenous ultrasound contrast agent designed for myocardial perfusion imaging.
- Clinical studies demonstrate SonoVue's safety and tolerability.
- The agent, when used with echocardiography, can detect perfusion abnormalities.
Findings:
- SonoVue coupled with echocardiography effectively identifies myocardial perfusion deficits.
- Results are validated against scintigraphic imaging, a gold standard.
- Various technical advancements enhance ultrasound perfusion assessment accuracy.
Implications:
- SonoVue offers a new dimension to echocardiography for myocardial perfusion evaluation.
- This technology has the potential to improve the diagnosis of ischemic heart disease.
- Further research into optimal ultrasound perfusion modalities is ongoing.